Evidence map›Paper›PMID 28716559›Full record

ReviewExperimental neurology2017

Optic nerve regeneration in mammals: Regenerated or spared axons?

Dietmar Fischer, Alan R Harvey, Vincent Pernet, Vance P Lemmon, Kevin K Park

Abstract readReview
In one paragraph

Review in Experimental neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Axon Regeneration: A Subcellular Extension in Multiple Dimensions.Cold Spring Harbor perspectives in biology · 2022
    Review
  12. Review
  13. Article
  14. CXCR4/CXCL12-mediated entrapment of axons at the injury site compromises optic nerve regeneration.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  15. Advances in Regeneration of Retinal Ganglion Cells and Optic Nerves.International journal of molecular sciences · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

Dietmar FischerDivision of Experimental Neurology, Department of Neurology, Heinrich-Heine-University of Düsseldorf, Merowingerplatz 1a, 40225 Düsseldorf, Germany.
Alan R HarveySchool of Human Sciences, The University of Western Australia, Perth, Western Australia, Australia; Perron Institute for Neurological and Translational Science, Perth, Western Australia, Australia.
Vincent PernetCUO-Recherche, Centre de recherche du CHU de Québec and Département d'ophtalmologie, Faculté de Médecine, Université Laval, Québec, Québec, Canada.
Vance P LemmonDepartment of Neurological Surgery, Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Kevin K ParkDepartment of Neurological Surgery, Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, FL 33136, USA. Electronic address: kpark@miami.edu.
University of Miami · USHeinrich Heine University Düsseldorf · DEUniversité Laval · CAUniversity of Western Australia · AU

Funding

Regeneration and Reconnection of Damaged Optic NerveR01EY022961 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PARK, KEVIN KYUNG · 2013 to 2019
$2.1M
Novel Targets to Promote RGC Axon Regeneration: Insights from Unique RGC CohortsU01EY027257 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BHATTACHARYA, SANJOY K, LEMMON, VANCE P · 2016 to 2018
$2.0M
Development and Characterization of Guided Optic Nerve RegenerationR21EY026668 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PARK, KEVIN KYUNG · 2016 to 2017
$422k
NEI NIH HHS R01 EY022961NEI NIH HHS R21 EY026668NEI NIH HHS U01 EY027257
6 · The paper itself

Abstract

Intraorbital optic nerve crush in rodents is widely used as a model to study axon regeneration in the adult mammalian central nervous system. Recent studies using appropriate genetic manipulations have revealed remarkable abilities of mature retinal ganglion cell (RGC) axons to regenerate after optic nerve injury, with some studies demonstrating that axons can then go on to re-innervate a number of central visual targets with partial functional restoration. However, one confounding factor inherent to optic nerve crush injury is the potential incompleteness of the initial lesion, leaving spared axons that later on could erroneously be interpreted as regenerating distal to the injury site. Careful examination of axonal projection pattern and morphology may facilitate separating spared from regenerating RGC axons. Here we discuss morphological criteria and strategies that may be used to differentiate spared versus regenerated axons in the injured mammalian optic nerve.

Indexed as

AnimalsHumansNerve RegenerationOptic Nerve InjuriesRetinal Ganglion CellsAxon growthAxon injuryAxon regenerationOptic nerve crushRetinal ganglion cells

Identifiers

PMID28716559
PMCPMC5564230
OpenAlexW2735696757

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.